Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Sep 12, 2006 by Edgar Snyder

Antibiotic Linked to Skin Problems


The antibiotic Factive, also known as gemifloxacin, used to treat acute sinus infections has been linked to serious skin reactions, according to the Food and Drug Administration (FDA). Compared to similar antibiotics, the risk of rashes associated with Factive is greater

The FDA plans to ask members of its anti-infective drugs advisory committee if the antibiotic’s benefits outweigh its risks. If the FDA advisory panel does not support the drug, the FDA will determine whether more study is needed. Factive gained FDA approval in 2003 as a treatment for pneumonia and acute bronchitis.

Drug litigation may involve co-counsel.

Source: “Skin problems cause worry over sinus drug.” The Associated Press. September 11, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers